Presloid John B, Novella Isabel S
Department of Medical Microbiology and Immunology, College of Medicine, The University of Toledo, 3055 Arlington Avenue, Toledo, OH 43614, USA.
Viruses. 2015 Jun 19;7(6):3226-40. doi: 10.3390/v7062768.
Due to high mutation rates, populations of RNA viruses exist as a collection of closely related mutants known as a quasispecies. A consequence of error-prone replication is the potential for rapid adaptation of RNA viruses when a selective pressure is applied, including host immune systems and antiviral drugs. RNA interference (RNAi) acts to inhibit protein synthesis by targeting specific mRNAs for degradation and this process has been developed to target RNA viruses, exhibiting their potential as a therapeutic against infections. However, viruses containing mutations conferring resistance to RNAi were isolated in nearly all cases, underlining the problems of rapid viral evolution. Thus, while promising, the use of RNAi in treating or preventing viral diseases remains fraught with the typical complications that result from high specificity of the target, as seen in other antiviral regimens.
由于高突变率,RNA病毒群体以一组密切相关的突变体形式存在,这些突变体被称为准种。易出错复制的一个后果是,当施加选择压力时,RNA病毒有迅速适应的潜力,包括宿主免疫系统和抗病毒药物。RNA干扰(RNAi)通过靶向特定mRNA进行降解来抑制蛋白质合成,并且这一过程已被开发用于靶向RNA病毒,显示出其作为抗感染治疗手段的潜力。然而,几乎在所有情况下都分离出了对RNAi具有抗性的含突变病毒,这凸显了病毒快速进化的问题。因此,虽然前景广阔,但在治疗或预防病毒性疾病中使用RNAi仍然充满了因靶点高度特异性而产生的典型并发症,这在其他抗病毒治疗方案中也可见到。